Mild Head Trauma in the Emergency Room: Assessment of the Risk of Intracranial Hemorrhage in Patients Receving Platelet Inhibitors.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1692 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The clinical signs presented by a patient with a mild head injury are highly variable but remain strongly predictive of brain damage. The reference examination for the diagnosis of post-traumatic intracranial hemorrhage is currently the cerebral scanner without injection of contrast medium. Magnetic resonance imaging (MRI) tends to surpass CT in equipped centers, except for suspected bone lesions. The time required to perform brain imaging depends on the patient's clinical condition, comorbidities and treatments.

The responsibility of antiplatelet agents in post-traumatic intracranial hemorrhage is currently discussed, particularly with aspirin.

The hypothesis is that there is no significant difference in the proportion of intracranial hemorrhage in patients on antiplatelet agents after mild head trauma, in the absence of other factors favoring the occurrence of intracranial hemorrhage.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatment and Outcome of Patients With Mild Head Injury

NCT07339319

Head Injury Trauma

RECRUITING

Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD

NCT06173427

Head Trauma

RECRUITING

Correct Timing of Head Imaging in Trauma

NCT05306951

Craniocerebral Trauma Platelet Aggregation Inhibitors

UNKNOWN

Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury

NCT04854954

Traumatic Brain Injury

COMPLETED

MRI for the Early Evaluation of Acute Intracerebral Hemorrhage

NCT01689402

Cerebral Hemorrhage Intracranial Arteriovenous Malformations Intracranial Hemorrhage, Hypertensive +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head Trauma Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient (≥18 years old)
* Visit to the emergency room of the Strasbourg University Hospital during 2017
* Victim of mild head trauma
* Patient who has given their consent to the reuse of their data for the purposes of this research.

* Patient who expressed their opposition to participating in the study
* Subject under safeguard of justice
* Subject under guardianship or curatorship
* Patient on anticoagulant
* Non-isolated head trauma (AVP, fall greater than 6 meters, etc.)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No